Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Alexza initiates phase IIb clinical trial of Staccato loxapine in migraine

Jan. 22, 2009

Novel mGluR5 receptor modulators with antipsychotic properties developed at GSK

Jan. 22, 2009

Recent Roche patent reports new antipsychotic tachykinin NK3 receptor antagonists

Jan. 22, 2009

Auris Medical commences phase IIb AM-111 trial in hearing loss

Jan. 21, 2009

Roche discloses novel tachykinin NK3 receptor antagonists

Jan. 21, 2009

New serotonin reuptake inhibitors and 5-HT1A receptor antagonists discovered at Wyeth

Jan. 21, 2009

ReNeuron receives U.K. approval for ground-breaking clinical trial of ReN-001 in ischemic stroke

Jan. 20, 2009

Alzheimer's Drug Discovery Foundation provides grant to Edunn Biotechnology

Jan. 20, 2009

AstraZeneca imparts novel metabotropic glutamate receptor oxadiazole ligands

Jan. 20, 2009

Peptimmune grants Novartis exclusive option to license PI-2301 for MS

Jan. 19, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 8, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...